AKT1 and hepatocellular carcinoma: LHPP, full name was Phospholysine phosphohistidine inorganic pyrophosphate phosphatase and was first reported in 2009 years [15, 16] and restrains human hepatocellular carcinoma (HCC) through the inhibition of PI3K/AKT signaling pathway [17].